Treatment of infection by human enterovirus D68
AssigneeAnsunBiopharma, Inc.
InventorRonald B. Moss
Life of this patent
Estimating the term…
Abstract
The present disclosure provides compositions and methods for treating an infection by EV-D68. In particular, the present disclosure provides methods that entail administering agents having an anchoring domain that anchors the compound to the surface of a target cell, and a sialidase domain that can act extracellularly to inhibit infection of a target cell by EV-D68.
Claims8
A method of treating Human enterovirus D68 infection in a patient, the method comprising administering to the patient an effective amount of a liquid composition comprising a polypeptide comprising the amino acid sequence of SEQ ID NO:15, wherein the composition is administered by inhalation.
Dependencies are inferred from the claim text.